Press release
Latest Research Of COPD Therapeutics in Asia-Pacific Market 2019- AstraZeneca, Boehringer Ingelheim, Novartis and GlaxoSmithKline
Researchmoz added Most up-to-date research on "COPD Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies" to its huge collection of research reports.Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. COPD occurs most often in older people, but can also affect people in their middle ages. It is a major cause of chronic morbidity and mortality globally. Many people suffer from this disease for years, and die from it or its complications, and it constitutes a substantial economic and social burden.
FREE | Request Sample is Available at: https://www.researchmoz.us/enquiry.php?type=S&repid=938607
Globally, the COPD burden is projected to increase in the coming decades because of continued exposure to COPD risk factors, and the increasing number of smokers. Increased smoking will result in a greater number of people living with the condition, thereby acting as a driver for revenue growth. The share of mortality attributed to COPD is expected to increase in the coming decades, when compared with other chronic diseases such as heart disease and stroke.
The marketed products landscape comprises a wide range of treatment options, including bronchodilator combinations, bronchodilator and ICS combinations, bronchodilator monotherapies and PDE-4 inhibitors. However, the market is undergoing a gradual transition, away from bronchodilator and ICS therapies and towards targeted and triple combination drug treatments. The market is set to be driven by recently launched products, and the approval of novel drugs that will supplement current market leaders and offer greater therapeutic options.
Scope
The COPD Asia-Pacific market will be valued at $7.3 billion in 2022, growing from $3.7 billion in 2015 at a CAGR of 10.2%.
Bronchodilators and ICS dominate the COPD market, but unmet needs exist in terms of safety and efficacy. Will the drugs under development fulfill the unmet needs of the COPD market?
Do branded therapies show continuous growth, and are they facing any competition from generics?
How will branded therapies be affected by upcoming pipeline therapies?
The pipeline contains a range of molecule types and molecular targets, including those that are well established in COPD, and novel, first-in-class therapies.
View Complete TOC with tables & Figures @ https://www.researchmoz.us/copd-therapeutics-in-asiapacific-markets-to-2022-growth-driven-by-rising-prevalence-growing-awareness-and-expected-launch-of-novel-therapies-report.html/toc
- Which molecular targets appear most frequently in the pipeline?
Will the pipeline address unmet needs related to limited targeted therapies for COPD patients?
What first-in-class triple combinations are due to enter the COPD market within the forecast period, and how will they compete with the currently marketed products?
Market forecasts indicate that Japan will contribute the most to the Asia-Pacific market value, due to the emergence of novel therapies.
How will the annual cost of therapy and market size vary between the five Asia-Pacific markets?
Various drivers and barriers will influence the market over the forecast period.
What barriers limit the uptake of premium-priced therapeutics in the assessed countries?
What factors are most likely to drive the market in these countries?
Reasons to buy
This report will allow you to -
Understand the current clinical and commercial landscape by considering disease pathogenesis, diagnosis, prognosis, and the treatment options available at each stage of diagnosis, including a clinical comparison of marketed therapies.
Visualize the composition of the COPD market in terms of dominant therapies, with their clinical and commercial standing. Unmet needs are highlighted to allow a competitive understanding of gaps in the current market.
Analyze the COPD pipeline and stratify pipeline therapies by stage of development, molecule type and molecular target.
Understand the potential of late-stage therapies, with extensive profiles of products that could enter the market over the forecast period, highlighting clinical performance, potential commercial positioning, and how they will compete with other therapies.
Predict COPD market growth in the five Asia-Pacific markets, with epidemiological and annual cost of therapy forecasts across India, China, Australia, South Korea and Japan, as well as analysis of the contributions of promising late-stage molecules to market growth.
Identify commercial opportunities in the COPD deals landscape by analyzing trends in licensing and co-development deals.
Make An Enquiry @ https://www.researchmoz.us/enquiry.php?type=E&repid=938607
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Follow us on LinkedIn @ http://bit.ly/1TBmnVG
Follow us on Blogger at : https://marketreportandanalysis.blogspot.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Latest Research Of COPD Therapeutics in Asia-Pacific Market 2019- AstraZeneca, Boehringer Ingelheim, Novartis and GlaxoSmithKline here
News-ID: 1586938 • Views: …
More Releases from COPD Therapeutics Market

COPD Therapeutics in Asia-Pacific Market Size, Growth Opportunities, Trends by M …
Researchmoz added Most up-to-date research on "COPD Therapeutics in Asia-Pacific Market Size, Growth Opportunities, Trends by Manufacturers | AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline and Novartis" to its huge collection of research reports.
Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. It occurs most often in older people, but can also affect the…

Growth Outlook: COPD Therapeutics Market is Booming Worldwide with Key Players
ResearchMoz include new market research report "COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies" to its huge collection of research reports.
Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. It occurs most often in older people, but can…

COPD Therapeutics in Asia-Pacific Market to 2023 - Research Analyst Focuses on C …
Researchmoz added Most up-to-date research on "COPD Therapeutics in Asia-Pacific Market to 2023 - Research Analyst Focuses on Companies like AstraZeneca, Boehringer Ingelheim, Novartis and GlaxoSmithKline" to its huge collection of research reports.
Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. It occurs most often in older people, but can also…

Asia-Pacific COPD Therapeutics Market Report Forecast to 2023| Abbott, AstraZene …
Albany, NY, 22nd January : Recent research and the current scenario as well as future market potential of "COPD Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Novel Therapies" globally.
Chronic obstructive pulmonary disease (COPD) is a term that refers to a large group of lung diseases characterized by obstruction of air flow that interferes with normal breathing. It occurs most…
More Releases for ICS
Europe Energy Measurement ICs Market Size 2025
"Introduction:
The Energy Measurement ICs market is experiencing significant growth, driven by the increasing demand for efficient energy management and the proliferation of smart devices. These integrated circuits play a crucial role in accurately measuring energy consumption in a wide range of applications, from smart meters to electric vehicle (EV) charging stations. Several key drivers are fueling this expansion, including the rising adoption of smart grid technologies, stringent government regulations promoting…
Battery Authentication ICs Market
Battery Authentication ICs Market Analysis:
The global Battery Authentication ICs Market size was estimated at USD 635 million in 2023 and is projected to reach USD 1183.35 million by 2030, exhibiting a CAGR of 9.30% during the forecast period.
North America Battery Authentication ICs market size was USD 165.46 million in 2023, at a CAGR of 7.97% during the forecast period of 2025 through 2030.
To Read Full Market Report -
https://semiconductorinsight.com/report/battery-authentication-ics-market/
Battery Authentication ICs…
Magnetic Position Sensor ICs Market
Magnetic position sensor ICs are tiny integrated circuits that detect the location of a magnet. They use the magnetic field to determine the magnet's position, either linear or rotary, without physically touching it. Magnetic position sensor ICs represent a transformative technology that is revolutionizing position sensing across various industries. As companies embrace automation, electrification, and innovation, magnetic position sensor ICs are poised to play an increasingly pivotal role in…
Phased Array Beamforming ICs Market: Advanced ICs Enabling Precise Beamforming i …
Global Phased Array Beamforming ICs Market Overview:
The Phased Array Beamforming ICs market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Phased Array Beamforming ICs market has experienced significant growth, driven by factors such as increasing consumer demand, technological advancements, and…
Global Industrial Control Systems (ICS) Security Market
As per latest findings on ICS security components and solutions conducted by Global Market Estimates, the Industrial Control Systems (ICS) Security Market will have a growth rate of 8.2% during the forecast period. Factors responsible for its growth are the increasing number of cybercrimes on the ICS system and initiatives taken by the government to adopt new gird technology across the globe to utilize energy and technology to its fullest…
Global Ethernet ICs Market Demand 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Ethernet ICs industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Ethernet ICs and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Scope of the Report:
The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025.…